Catalyst Wire Dossier Catalyst Wire Dossier

Meningococcal ACYW135 polysaccharide conjugate vaccine

Meningococcal conjugate vaccine ACYW135 · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Meningococcal ACYW135 polysaccharide conjugate vaccine, covering 2016-08-26 to 2024-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months [Phase 3]

See pricing